
Poliomyelitis (Polio) - World Health Organization (WHO)
Aug 16, 2020 · Polio vaccine, given multiple times, almost always protects a child for life. The development of effective vaccines to prevent paralytic polio was one of the major medical breakthroughs of the 20th century. There are six different vaccines to stop polio transmission: Inactivated polio vaccine (IPV) – protects against poliovirus types 1, 2, and 3
Two Polio Vaccines - World Health Organization (WHO)
Feb 24, 2025 · Poliomyelitis (polio) is a highly infectious viral disease that largely affects children under 5 years of age. The virus is transmitted by person-to-person spread mainly through the faecal-oral route or, less frequently, by a common vehicle (e.g. contaminated water or food) and multiplies in the intestine, from where it can invade the nervous system and cause paralysis.
Poliomyelitis - World Health Organization (WHO)
Oct 22, 2024 · Polio vaccine, given multiple times, can protect a child for life. There are two vaccines available: oral polio vaccine and inactivated polio vaccine . Both are effective and safe, and both are used in different combinations worldwide, depending on local epidemiological and programmatic circumstances, to ensure the best possible protection to ...
Immunization, Vaccines and Biologicals - World Health …
Jun 24, 2022 · A child receiving oral polio drops. After being declared polio-free by World Health Organization officials in 2014, Indonesia is observing National Polio Immunization Week by vowing to inoculate millions ©
Poliomyelitis - World Health Organization (WHO)
Oct 27, 2023 · Oral polio vaccine (OPV) contains an attenuated (weakened) vaccine-virus, activating an immune response in the body. When a child is immunized with OPV, the weakened vaccine-virus replicates in the intestine for a limited period, thereby developing immunity by building up antibodies. During this time, the vaccine-virus is also excreted.
Polio vaccines: WHO position paper – June 2022
Jun 24, 2022 · In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization …
Poliomyelitis - World Health Organization (WHO)
Oral polio vaccine was first introduced in 1961 and consists of a mixture of the three live attenuated poliovirus serotypes (Sabin types 1, 2 and 3), selected for their lower neurovirulence and reduced transmissibility. In addition to trivalent OPV (tOPV), which is used in many countries for routine or supplemental vaccination, monovalent OPVs ...
Safety profile of nOPV2 vaccine - World Health Organization (WHO)
Mar 1, 2024 · The first polio vaccine was developed by Jonas Salk, from formaldehyde-inactivated wild polio viruses. Salk’s IPV was tested and proved highly efficacious against paralytic poliomyelitis in a large clinical trial conducted in US schoolchildren in 1954, which was rapidly followed by licensure of the product and implementation of mass ...
Poliomyelitis (polio) in China - World Health Organization (WHO)
Poliomyelitis (polio) is a highly infectious viral disease that largely affects children under 5 years of age. The virus is transmitted by person-to-person spread mainly through the faecal-oral route or, less frequently, by a common vehicle (e.g. contaminated water or food) and multiplies in the intestine, from where it can invade the nervous system and cause paralysis.
Circulating vaccine-derived poliovirus type 2 – Kenya
On 11 July 2023, WHO received an official report regarding the detection of a circulating vaccine-derived poliovirus type 2 (cVDPV2) in two acute flaccid paralysis (AFP) cases and two asymptomatic healthy children community contacts from Hagadera refugee camp, in Kenya, the second largest refugee camp in the world with over 100 000 refugees. The genetic sequencing …
- Some results have been removed